An open clinical trial of cortexin in treatment of brain ischemia
Observational study · 2014
- What was studied
- Analysis of 500 patients with stage II brain ischemia
- Main finding
- The authors describe before/after cognitive, affective, and neurological changes in an open treatment analysis.
Reported findings and study design
Open screening program: 50,000 patients in 70 cities; analyzed subgroup 500 with stage-II brain ischemia, mean age 63.7 ± 10.23. Cortexin 10 mg/day for ten days; assessments before treatment and days 11 and 30.
Population or model Analysis of 500 patients with stage II brain ischemia
Dose, route and schedule
Cortexin: 10 mg/day for ten days. The route is not specified in the indexed abstract.
Protocol source ↗ · Indexed publication abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Analyzed treatment sample | 500 | The 50,000-person screening program is not the analyzed trial sample |
| Cognitive/affective and focal symptoms | Improvement reported | No numerical score changes supplied |
Values describe this study and its comparison. Unreported effect sizes and missing denominators have not been inferred.
Source for these results ↗ · Reviewed 2026-10-29
Study limitations and source details
Study limitations
- No untreated comparison is described in the abstract.
- The analysis sample is 500; the larger screening population is not the analyzed sample.
- This paper did not measure wearable sleep stages and cannot validate the n=1 diary.
Source details
PubMed record and English abstract checked. Open interventional report; grouped here with uncontrolled observational evidence.
Sources checked
Citation
V. V. Mashin, L. A. Belova, O. I. Chaplanova, A. F. Khusnullina, A. M. Manasian. An open clinical trial of cortexin in treatment of brain ischemia Zh Nevrol Psikhiatr Im S S Korsakova. 114(9):49–52